Hypertension and Aldosterone disorders
Gene: CYP11B2
Multiple (>>3) unrelated individuals reported with hypoaldosteronism due to corticosterone methyloxidase type I or II deficiency.
CYP11B2 catalyses both the penultimate and ultimate steps in aldosterone biosynthesis. Variants affecting the penultimate step cause CMO I deficiency, while variants affecting only or predominantly the ultimate step cause CMO II deficiency, and the two overlap phenotypically but have distinct biochemical features (PMID:8772616, 9814506).Created: 21 Sep 2020, 6:49 a.m. | Last Modified: 21 Sep 2020, 6:49 a.m.
Panel Version: 0.15
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600).
Publications
Variants in this GENE are reported as part of current diagnostic practice
Tag treatable tag was added to gene: CYP11B2.
Gene: cyp11b2 has been classified as Green List (High Evidence).
Phenotypes for gene: CYP11B2 were changed from to Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600)
Publications for gene: CYP11B2 were set to
Mode of inheritance for gene: CYP11B2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: CYP11B2 was added gene: CYP11B2 was added to Renal hypertension and disorders of aldosterone metabolism_KidGen. Sources: Expert Review Green,KidGen_AldoHypertension v38.1.0 Mode of inheritance for gene: CYP11B2 was set to Unknown